Artificial Intelligence And Machine Learning In Oncology: Enhancing Accuracy In Radiological And Histological Image Analysis
Downloads
Early and precise detection of malignant tumors remains a critical bottleneck in oncological care. Traditional diagnostic methods rely heavily on the visual assessment of radiological scans and histological slides by medical experts, introducing subjective variability and susceptibility to diagnostic fatigue. This study evaluates an advanced deep-learning framework designed to enhance diagnostic precision across both radiological and histological domains. Leveraging an ensemble architecture of Deep Convolutional Neural Networks (CNNs), the system was trained on a multi-center dataset containing 1,200 chest Computed Tomography (CT) scans and 850 digitalized histological biopsy tissue specimens. The experimental results demonstrate that the AI-driven model achieved an overall accuracy of 95.4%, yielding a sensitivity of 94.2% for early-stage pulmonary nodules and 96.5% specificity for identifying cellular atypia in histological samples. Comparisons with an independent baseline group of board-certified clinical readers indicated a statistically significant reduction in both false-negative and false-positive rates (p < 0.01). By serving as a highly precise, automated objective tool, this framework holds substantial promise for standardizing oncology screening protocols, accelerating diagnostic workflows, and mitigating diagnostic errors in clinical settings.
[1] H. Sung et al., “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA Cancer J. Clin., vol. 71, no. 3, pp. 209–249, May 2021.
[2] A. Hosny, C. Parmar, J. Quackenbush, L. H. Schwartz, and H. J. W. L. Aerts, “Artificial intelligence in radiology,” Nat. Rev. Cancer, vol. 18, no. 8, pp. 500–510, Aug. 2018.
[3] D. Sulaymonov and I. Sodiqov, “Comparative evaluation of the diagnostic accuracy of CT and MRI in the detection of liver metastases,” South Aral Region Med. J., vol. 2, no. Maxsus son-2, pp. 514–520, 2026.
[4] M. K. K. Niazi, A. V. Parwani, and M. N. Gurcan, “Digital pathology and artificial intelligence,” Lancet Oncol., vol. 20, no. 5, pp. e253–e261, May 2019.
[5] E. J. Topol, “High-performance medicine: The convergence of human and artificial intelligence,” Nat. Med., vol. 25, no. 1, pp. 44–56, Jan. 2019.
[6] W. L. Bi et al., “Artificial intelligence in cancer imaging: Clinical challenges and applications,” CA Cancer J. Clin., vol. 69, no. 2, pp. 127–157, Mar. 2019.
[7] G. Litjens et al., “A survey on deep learning in medical image analysis,” Med. Image Anal., vol. 42, pp. 60–88, Dec. 2017.
[8] Y. LeCun, Y. Bengio, and G. Hinton, “Deep learning,” Nature, vol. 521, no. 7553, pp. 436–444, May 2015.
[9] A. Esteva et al., “Deep learning-enabled medical computer vision,” npj Digit. Med., vol. 4, Art. no. 5, Jan. 2021.
[10] D. Ardila et al., “End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography,” Nat. Med., vol. 25, no. 6, pp. 954–961, Jun. 2019.
[11] G. Campanella et al., “Clinical-grade computational pathology using weakly supervised deep learning on whole slide images,” Nat. Med., vol. 25, no. 8, pp. 1301–1309, Aug. 2019.
[12] N. Coudray et al., “Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning,” Nat. Med., vol. 24, no. 10, pp. 1559–1567, Oct. 2018.
[13] B. E. Bejnordi et al., “Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer,” JAMA, vol. 318, no. 22, pp. 2199–2210, Dec. 2017.
[14] K. He, X. Zhang, S. Ren, and J. Sun, “Deep residual learning for image recognition,” in Proc. IEEE Conf. Comput. Vis. Pattern Recognit. (CVPR), Las Vegas, NV, USA, 2016, pp. 770–778.
[15] O. Oktay et al., “Attention U-Net: Learning where to look for the pancreas,” 2018, arXiv:1804.03999.
[16] O. Ronneberger, P. Fischer, and T. Brox, “U-Net: Convolutional networks for biomedical image segmentation,” in Proc. Med. Image Comput. Comput.-Assist. Intervent. (MICCAI), Munich, Germany, 2015, pp. 234–241.
[17] C. Shorten and T. M. Khoshgoftaar, “A survey on image data augmentation for deep learning,” J. Big Data, vol. 6, Art. no. 60, 2019.
[18] D. P. Kingma and J. Ba, “Adam: A method for stochastic optimization,” in Proc. Int. Conf. Learn. Represent. (ICLR), San Diego, CA, USA, 2015.
[19] C. J. Kelly, A. Karthikesalingam, M. Suleyman, G. Corrado, and D. King, “Key challenges for delivering clinical impact with artificial intelligence,” BMC Med., vol. 17, Art. no. 195, 2019.
[20] B. Recht, R. Roelofs, L. Schmidt, and V. Shankar, “Do ImageNet classifiers generalize to ImageNet?” in Proc. Int. Conf. Mach. Learn. (ICML), Long Beach, CA, USA, 2019, pp. 5389–5400.
[21] D. S. Char, N. H. Shah, and D. Magnus, “Implementing machine learning in health care—Addressing ethical challenges,” N. Engl. J. Med., vol. 378, no. 11, pp. 981–983, Mar. 2018.
[22] R. R. Selvaraju et al., “Grad-CAM: Visual explanations from deep networks via gradient-based localization,” in Proc. IEEE Int. Conf. Comput. Vis. (ICCV), Venice, Italy, 2017, pp. 618–626.

